Your allergy medication probably hasn’t stopped working — your allergies have changed, and the season itself has shifted underneath you. True pharmacological tolerance to modern second-generation antihistamines like Claritin, Zyrtec, and Allegra is uncommon, according to research published in the Annals of Allergy, Asthma & Immunology in 2023. Studies show these medications maintain their effectiveness for 30 to 180 days of continuous use. So if your pills seem useless by late spring, the explanation almost certainly lies elsewhere: new allergen sensitivities, longer pollen seasons driven by climate change, rebound congestion from overused decongestants, or simply inconsistent timing. Consider someone who managed grass pollen perfectly well with loratadine for a decade, only to find themselves miserable every April starting in their forties.
They haven’t built tolerance to the drug. They’ve developed a new sensitivity — perhaps to tree pollen or dust mites — that their single-mechanism antihistamine was never designed to address. Meanwhile, the pollen season itself has quietly expanded by roughly 20 days compared to 1990, and plants are producing about 21 percent more pollen than they did three decades ago. The target has moved, and the medication hasn’t moved with it. This article breaks down what’s actually happening when allergy medications seem to fail, why climate change is compounding the problem in measurable ways, what the 2026 season looks like so far, and what allergists recommend when your current regimen stops cutting it — including strategies that matter for older adults managing cognitive health alongside chronic allergies.
Table of Contents
- Is Your Body Actually Building Tolerance to Allergy Medication?
- The Hidden Culprits Behind Medication Failure — and When to Worry
- Climate Change Is Rewriting Allergy Season — By the Numbers
- What Allergists Actually Recommend When Your Medication Fails
- The Cognitive Cost of Poor Allergy Management in Older Adults
- The 2026 Season Is Already Ahead of Schedule
- What’s Coming Next in Allergy Treatment
- Conclusion
- Frequently Asked Questions
Is Your Body Actually Building Tolerance to Allergy Medication?
The short answer for most people is no. The concept of tachyphylaxis — where your body adapts to a drug and requires higher doses for the same effect — does apply to some medications, but modern antihistamines are largely resistant to this phenomenon. The 2023 evidence review in the Annals of Allergy, Asthma & Immunology confirmed that second-generation antihistamines maintain their histamine-blocking activity over extended periods. Where tolerance does develop rapidly is with first-generation antihistamines like diphenhydramine (Benadryl), but even there, the tolerance is to the sedative side effects, not to the anti-allergy mechanism itself. Your body adjusts to the drowsiness within just a few days of consistent use, which can create the false impression that the entire drug has lost its punch. There is one important exception worth flagging, particularly for older adults.
In 2025, the FDA issued a warning that abruptly stopping cetirizine (Zyrtec) or levocetirizine (Xyzal) after long-term use can trigger severe pruritus — intense, widespread itching that has nothing to do with allergies. The agency now recommends a gradual taper rather than cold-turkey cessation. For anyone managing a complex medication schedule, which is common among people with dementia or those caring for someone with cognitive decline, this kind of rebound effect can be easily mistaken for worsening allergies or even a new medical problem. It’s worth discussing any changes to long-term antihistamine use with a pharmacist or physician. So if true tolerance is rare, why does it genuinely feel like the medication stopped working? Because the problem has changed. New allergies can develop at any age. You may have controlled one allergen for years and then developed sensitivity to dust mites, mold, or pet dander that your current medication doesn’t fully address. Your single antihistamine is still blocking histamine — it’s just that histamine is no longer the only thing driving your symptoms.
The Hidden Culprits Behind Medication Failure — and When to Worry
Beyond new sensitivities, several practical factors explain why allergy relief fades, and most of them are correctable. Rebound congestion from nasal decongestants is one of the most common and least understood. Sprays containing oxymetazoline or phenylephrine, used for more than three consecutive days, can cause a paradoxical worsening of nasal congestion that takes months to fully resolve. People often blame their antihistamine for failing when the real saboteur is the decongestant spray they’ve been leaning on as backup. Inconsistent use is another frequent problem. Allergy medications work best when taken continuously throughout allergy season, not reactively like ibuprofen for a headache. Stopping when symptoms improve allows the allergic cascade to restart, and catching up takes time.
Experts recommend starting allergy medications one to two weeks before peak season for best efficacy — a window that many people miss entirely. However, if you’re taking antihistamines and genuinely seeing zero benefit after two to three weeks of consistent daily use during confirmed high-pollen periods, the issue may not be timing. It may be that your symptoms are driven by something antihistamines don’t address well, such as non-allergic rhinitis, nasal polyps, or chronic sinusitis. These conditions mimic allergies convincingly but require different treatment. A persistent lack of response warrants an evaluation rather than simply stacking more over-the-counter products. For older adults and dementia caregivers, there’s an additional wrinkle. First-generation antihistamines like benadryl carry significant anticholinergic burden, which has been linked to increased confusion, fall risk, and potentially accelerated cognitive decline. If someone with memory concerns is using diphenhydramine regularly because their “real” allergy medication doesn’t seem to work, the consequences extend well beyond stuffy sinuses.
Climate Change Is Rewriting Allergy Season — By the Numbers
The feeling that allergy seasons are getting worse isn’t subjective. A landmark PNAS study analyzing data from 1990 to 2018 found that allergy season now starts approximately 20 days earlier and lasts about eight days longer than it did in 1990, with climate change identified as the dominant driver. Pollen production increased roughly 21 percent nationwide during that same period, with the greatest surges concentrated in Texas and the Midwest. Plants exposed to higher carbon dioxide levels produce about 20 percent more pollen than they did 50 years ago — more fuel for immune systems already primed to overreact. The freeze-free growing season has lengthened in 87 percent of 198 U.S. cities studied, extending by an average of 21 days between 1970 and 2025. Reno, Nevada saw the most dramatic shift: 100 additional frost-free days.
That means longer windows for pollen-producing plants to thrive and more cumulative exposure for the roughly one in four U.S. adults and one in five children who suffer from seasonal allergies. The downstream effects are significant — allergies cause approximately 3.8 million missed work and school days annually, and a two-degree-Celsius warming scenario could drive a 17 percent annual increase in asthma-related emergency room visits among children due to pollen alone, according to the U.S. EPA. For someone who has been managing allergies the same way for 20 years, these shifts matter enormously. The medication regimen that worked in 2005 was calibrated for a shorter, less intense season. The pollen landscape of 2026 is materially different, and projections suggest up to a 200 percent increase in pollen production by the end of the century under high-emission scenarios. Adaptation isn’t optional.
What Allergists Actually Recommend When Your Medication Fails
The most common expert recommendation is not to increase your dose but to switch antihistamine classes. Loratadine (Claritin), cetirizine (Zyrtec), and fexofenadine (Allegra) work through the same receptor but have different pharmacological profiles. If one has plateaued for you, rotating to another can sometimes restore effective relief. This is a low-risk strategy worth trying before escalating to prescription options. The tradeoff is that each antihistamine has a slightly different side-effect profile — cetirizine is more likely to cause drowsiness than fexofenadine, for instance, which matters considerably for anyone already dealing with fatigue, brain fog, or cognitive impairment. Combining treatments is the next step.
An oral antihistamine paired with a nasal corticosteroid like fluticasone (Flonase) provides synergistic relief by addressing different parts of the allergic response — the antihistamine blocks histamine while the corticosteroid reduces the underlying nasal inflammation. For many people, this combination outperforms either product alone. A supervised drug holiday of three to 14 days, where you stop the antihistamine entirely under medical guidance, can also help receptors reset, though the 2025 FDA warning about cetirizine withdrawal itching makes medical supervision particularly important for this approach. The only disease-modifying treatment available is immunotherapy — allergy shots or sublingual drops — which gradually retrains the immune system to tolerate specific allergens. Unlike antihistamines, which manage symptoms, immunotherapy addresses the root cause and can provide long-term relief even after treatment ends. The limitation is time: traditional allergy shots require three to five years of regular injections, and the commitment can be difficult for older adults with mobility challenges or cognitive concerns that make frequent medical appointments burdensome.
The Cognitive Cost of Poor Allergy Management in Older Adults
Undertreated allergies carry consequences that extend beyond sneezing and congestion, particularly for people concerned about brain health. Chronic nasal congestion disrupts sleep quality, and poor sleep is one of the most well-established modifiable risk factors for cognitive decline. Someone whose allergy medication has functionally stopped working — for whatever reason — may be experiencing months of fragmented sleep without connecting it to their allergy management gap. The medication choices themselves carry cognitive stakes. First-generation antihistamines cross the blood-brain barrier readily and block acetylcholine, a neurotransmitter critical for memory and learning.
The American Geriatrics Society’s Beers Criteria lists diphenhydramine as potentially inappropriate for older adults precisely because of its anticholinergic and sedative effects. Yet it remains widely available over the counter, and people frustrated by the failure of their second-generation antihistamine sometimes reach for Benadryl as a more “powerful” alternative. This is exactly the wrong escalation for anyone with existing cognitive concerns or a family history of dementia. Second-generation options — cetirizine, loratadine, fexofenadine — were specifically designed to minimize central nervous system penetration. Even when they seem less effective, they remain the safer class for brain health. The warning here is direct: do not substitute a first-generation antihistamine for a perceived failure of a second-generation one without consulting a physician, especially in adults over 65.
The 2026 Season Is Already Ahead of Schedule
Spring 2026 is arriving two to three weeks early in parts of Texas, Louisiana, Colorado, Kansas, and Missouri, according to Climate Central’s 2026 analysis. Dr. Stanley Fineman, an allergist with over 40 years of clinical experience, has adjusted his guidance accordingly — he now recommends patients start their allergy medications on Valentine’s Day, February 14, rather than the traditional benchmark of St.
Patrick’s Day, March 17. That one-month shift reflects how substantially the pollen calendar has migrated. For caregivers managing medication schedules for someone with dementia, this earlier start date is a practical detail worth noting on the calendar. A person with cognitive impairment may not recognize or report worsening allergy symptoms, and the resulting congestion, poor sleep, and general discomfort can manifest as increased agitation or confusion — symptoms easily attributed to the dementia itself rather than to a treatable seasonal condition.
What’s Coming Next in Allergy Treatment
Researchers are exploring H4 receptor antagonists as a new class of allergy medication. Unlike current antihistamines that target the H1 receptor, H4 antagonists work on a receptor involved in inflammation and vascular leakage. Preclinical studies in models of asthma and dermatitis have shown promise, but no H4 receptor antagonist has received clinical approval as of 2025.
The timeline to market remains uncertain, and these drugs would likely complement rather than replace existing antihistamines. In the meantime, the most forward-looking strategy available today remains immunotherapy, which is also the only approach that can fundamentally change the trajectory of allergic disease rather than just managing annual symptoms. For older adults and their families, the practical calculus involves weighing the multi-year commitment against the cumulative burden of decades of worsening seasons ahead — seasons that climate data tells us will only intensify.
Conclusion
Your allergy medication almost certainly hasn’t lost its effectiveness through tolerance. The far more likely explanations are new allergen sensitivities, inconsistent dosing, rebound congestion from overused decongestant sprays, or — increasingly — a pollen season that has fundamentally shifted in timing and intensity due to climate change. The 2026 season started weeks ahead of historical norms, pollen counts are measurably higher than a generation ago, and the trend line points in only one direction.
The practical next steps are straightforward: start medications earlier (by mid-February rather than mid-March), use them consistently rather than reactively, consider combining an oral antihistamine with a nasal corticosteroid, and rotate antihistamine classes before assuming the medication has failed. For older adults and anyone concerned about cognitive health, avoid first-generation antihistamines like Benadryl, taper cetirizine gradually rather than stopping abruptly, and treat uncontrolled allergies as a sleep and brain health issue — not just a comfort problem. If over-the-counter strategies aren’t enough, immunotherapy remains the only option that can change the underlying disease rather than chasing its symptoms.
Frequently Asked Questions
Can you actually build a tolerance to Zyrtec or Claritin?
True pharmacological tolerance to second-generation antihistamines is uncommon. Research published in 2023 in the Annals of Allergy, Asthma & Immunology shows these medications maintain effectiveness for 30 to 180 days of continuous use. What changes is usually the allergic challenge itself — new sensitivities, more pollen, or longer seasons — rather than your body’s response to the drug.
Is it safe to stop taking Zyrtec suddenly after using it for months?
The FDA issued a 2025 warning that abruptly stopping cetirizine (Zyrtec) or levocetirizine (Xyzal) after long-term use can cause severe itching unrelated to allergies. A gradual taper is now recommended. Talk to your pharmacist or doctor about a step-down schedule.
Why are my allergies worse now than they were 10 years ago?
Climate change has extended allergy season by approximately 20 days and increased pollen production by about 21 percent since 1990. The freeze-free growing season has lengthened in 87 percent of major U.S. cities. You may also have developed new allergen sensitivities, which can happen at any age.
Are antihistamines safe for people with dementia or older adults?
Second-generation antihistamines (cetirizine, loratadine, fexofenadine) are generally preferred for older adults because they minimally cross the blood-brain barrier. First-generation antihistamines like diphenhydramine (Benadryl) are listed as potentially inappropriate for older adults by the American Geriatrics Society due to anticholinergic effects that can worsen confusion and increase fall risk.
When should I start taking allergy medication in 2026?
Allergists now recommend starting by mid-February rather than mid-March. Dr. Stanley Fineman, with over 40 years in allergy medicine, specifically recommends Valentine’s Day (February 14) as the new start date, reflecting how much earlier pollen seasons now begin in many parts of the country.
